MSLN and neoplasm: When we investigated the effects of tumor-derived EVs on naïve neutrophils, we observed that even a short exposure to EVs from tazemetostat-treated cells prompted a shift in these neutrophils toward a protumor phenotype, marked by elevated levels of PD-L1 and MSLN on their surface.